UK’s health and social care watchdog has decided against recommending Mounjaro, Eli Lilly’s weight loss drug for adults with diabetes. The National Institute for Health and Care Excellence (NICE) in the UK released draft guidance stating that they need more information about tirzepatide, the active ingredient in Mounjaro. “Our committee can see the promise in tirzepatide, but…
Diabetes Drug Shown to Effectively Trim Fat With Minimal Muscle Loss: Study
Based on a recent analysis, Mounjaro, an approved medication for Type 2 diabetes, has shown promise in reducing fat mass without significant loss of lean mass, which can improve overall body composition. In contrast, popular weight loss drugs like Wegovy and Ozempic have been found to result in the loss of lean mass instead of…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`